NCT02666690View on ClinicalTrials.gov

Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
GIST Metastatic CancerBreast Metastatic CancerKidney Metastatic CancerColon Metastatic CancerRectal Metastatic Cancer
Interventions
DEVICE

CEUS (Contrast-enhanced ultrasound)

Each patient will be performed 2 contrast echocardiography (a pre-prandial - a post-prandial) before the antiangiogenic treatment, at D15 and D30.

Trial Locations (1)

94805

Gustave Roussy Cancer Campus Grand Paris, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT02666690 - Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast | Biotech Hunter | Biotech Hunter